+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Technology, and End User

  • ID: 5331862
  • Report
  • May 2021
  • Region: Europe
  • The Insight Partners
UP TO OFF
until Jan 15th 2022

FEATURED COMPANIES

  • Illumina, Inc
  • Lexogen GmbH
  • New England Biolabs
  • Norgen Biotek Corp
  • Perkin Elmer, Inc.
  • QIAGEN
The Europe miRNA sequencing and assay market is expected to reach US$ 144.87 million by 2027 from US$ 62.30 million in 2019; it is estimated to grow at a CAGR of 11.3% from 2020 to 2027. The widening application range of microRNAs and rise in funding for genomics research. However, challenges associated with the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.



MicroRNAs (miRNAs) are noncoding RNAs that are partially complementary to messenger RNA (mRNA). They are known to downregulate the expression, which makes them vital regulators of important cellular functions. Being involved in the process of differentiation, they act as markers in cell type identification. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. Furthermore, new discoveries regarding the role of miRNAs in disease development have made them a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, rise in funding of genomic research to identify new molecules to diagnose and treat diseases, and consequent expansion of the range of applications of miRNAs are driving the growth of the miRNA sequencing and assay market in Europe.

The COVID-19 pandemic has been having some serious effects on European countries. The miRNA sequencing and assay market in the region witnessed shortfall at the beginning of the pandemic crisis due to disruptions in supply chain and lowered demands due to lockdown imposed by many European countries. However, later, the demand for the miRNA sequencing and assay products increased drastically with supportive government initiatives. Many private research organizations have expanded their research teams and projects to accelerate studies related to SARS-CoV-2. For instance, QIAGEN, Germany, a pioneer in next-generation sequencing (NGS), has expanded its integrated coronavirus next-generation sequencing platforms and software solutions to accelerate COVID-19 research. Hence, the COVID-19 pandemic has been supporting the Europe miRNA sequencing and assay market growth.

The Europe miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on technology, the Europe miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.

Based on end user, the Europe miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the period.

A few of the primary and secondary sources associated with this report on the Europe miRNA sequencing and assay market are the European Federation of Pharmaceutical Industries and Association (EFPIA), Spanish Society of Medical Oncology (SCOM), and Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe miRNA sequencing and assay market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe miRNA sequencing and assay market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Illumina, Inc
  • Lexogen GmbH
  • New England Biolabs
  • Norgen Biotek Corp
  • Perkin Elmer, Inc.
  • QIAGEN
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe miRNA Sequencing and Assay Market - By Product
1.3.2 Europe miRNA Sequencing and Assay Market - By Technology
1.3.3 Europe Global miRNA Sequencing and Assay Market - By End User
1.3.4 Europe miRNA Sequencing and Assay Market - By Country

2. miRNA Sequencing and Assay Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe miRNA Sequencing and Assay - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe - PEST Analysis
4.3 Expert Opinions

5. miRNA Sequencing and Assay Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Widening Range of MicroRNA Applications
5.1.2 Rise in Funding for Genomics Research
5.2 Market Restraints
5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics
5.3 Market Opportunities
5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis

6. miRNA Sequencing and Assay Market - Europe Analysis
6.1 Europe miRNA Sequencing and Assay Market Revenue Forecast and Analysis

7. miRNA Sequencing and Assay Market Analysis - By Product
7.1 Overview
7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
7.3 Library Preparation
7.3.1 Overview
7.3.2 Library Preparation: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)

8. miRNA Sequencing and Assay Market Analysis - By Technology
8.1 Overview
8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Nanopore
8.4.1 Overview
8.4.2 Nanopore: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Ion Semiconductor Sequencing
8.5.1 Overview
8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)

9. miRNA Sequencing and Assay Market Analysis - By End User
9.1 Overview
9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)
9.3 Research Institute
9.3.1 Overview
9.3.2 Research Institute: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Academia
9.4.1 Overview
9.4.2 Academia: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)

10. miRNA Sequencing and Assay Market - Europe Analysis
10.1 Europe: miRNA Sequencing and Assay Market
10.1.1 Overview
10.1.2 Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
10.1.3 Germany: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Germany: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Germany miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Germany miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Germany miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.4 UK: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UK: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UK miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.4.3 UK miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.4.4 UK miRNA Sequencing and Assay Market, by End User- Revenue and Forecast to 2027 (USD Million)
10.1.5 France: Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.1 France: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.5.2 France miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.5.3 France miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.5.4 France miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 Spain: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Spain: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Spain miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Spain miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Spain miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.7 Italy: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Italy: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Italy miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Italy miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Italy miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 Rest of Europe: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Europe: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Europe miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Rest of Europe miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Rest of Europe miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Europe miRNA Sequencing and Assay Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview

13. Company Profiles
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Takara Bio Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 New England Biolabs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Norgen Biotek Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lexogen GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

List of Tables
Table 1. Germany miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. Germany miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 3. Germany miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 4. UK miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 5. UK miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 6. UK: miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million).
Table 7. France miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 8. France miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. France miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 10. Spain miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 11. Spain miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Spain miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 13. Italy miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. Italy miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 15. Italy miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Europe miRNA Sequencing and Assay Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Europe miRNA Sequencing and Assay Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of Europe miRNA Sequencing and Assay Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, miRNA Sequencing and Assay Market

List of Figures
Figure 1. miRNA Sequencing and Assay Market Segmentation
Figure 2. miRNA Sequencing and Assay Market Segmentation, By Country
Figure 3. miRNA Sequencing and Assay Market Overview
Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth
Figure 5. Europe miRNA Sequencing and Assay Market - Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints
Figure 8. Europe miRNA Sequencing and Assay Market - Revenue Forecast and Analysis - 2019- 2027
Figure 9. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
Figure 10. Library Preparation: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Consumables: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)
Figure 13. Sequencing by Synthesis: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Nanopore: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)
Figure 17. Research Institute: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Academia: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Europe: miRNA Sequencing and Assay Market, by Key Country - Revenue (2019) (USD Million)
Figure 21. Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
Figure 22. Germany: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 23. UK: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 24. France: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 25. Spain: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 26. Italy: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 27. Rest of Europe: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in European Country Markets
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Illumina, Inc
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • Perkin Elmer, Inc.
  • Takara Bio Inc.
  • New England Biolabs
  • Norgen Biotek Corp
  • TriLink BioTechnologies Inc.
  • Lexogen GmbH
  • Oxford Nanopore Technologies
Note: Product cover images may vary from those shown
Adroll
adroll